also on other fortune lists

company facts

g500 stats

Global 500

Richard Levine—Alamy Stock Pho Alamy Stock Photo


Johnson & Johnson



The 132-year-old company, which specializes in pharmaceuticals, consumer health care, and medical devices, sells a wide array of health and beauty products including the Johnson’s Baby line, Neutrogena, Listerine, Band Aids, Tylenol, and Motrin. The company has been at the center of lawsuits concerning products that contain talc and their possible link to ovarian cancer and lung-related cancers, and has also been sued in connection with the U.S. opioid epidemic. But even amid legal conflicts and competition and pricing pressures in the industry, the company saw domestic sales increase 5.4% and international sales increase 7.4% in 2017. The company raised its sales outlook for 2018 due to the high performance of its pharmaceutical business, particularly cancer drugs.

Looking for leads, investment insights, or competitive intelligence?


Alex Gorsky


Health Care



HQ Location

New Brunswick, N.J.

Years on Global 500 List




Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$76,4506.3%
Profits ($M)$1,300.0-92.1%
Assets ($M)$157,303
Total Stockholder Equity ($M)$60,160
Profit Ratios
Profit as % of Revenues1.7%
Profits as % of Assets0.8%
Profits as % of Stockholder Equity2.2%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Johnson & Johnson

Advertisers Are Giving People With 1,000 Instagram Followers Endorsement Deals

Some of the 'nanoinfluencers' aren't even old enough for day jobs.

Read More →
What Pharma Giant Johnson & Johnson's CEO Has to Say About the Drug Price Debate

J&J chief Alex Gorsky had some thoughts to share at the Fortune Global Forum.

Read More →
These Are the Health Care Companies Poised for Explosive Growth

From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.

Read More →
Data Sheet—Fortune Global Forum Talks China, Drug Pricing, and Nobel Winners

This is your Data Sheet newsletter for Tuesday, October 16, 2018.

Read More →